Vericel (VCEL) Inventory Average (2014 - 2026)
Vericel recorded quarterly Inventory Average of $18.0 million in Q1 2026, up 0.55% quarter-over-quarter from $17.9 million in Q4 2025, and up 4.15% year-over-year from $17.2 million in Q1 2025.
Vericel's Inventory Average history runs 13 years deep, the most recent figure standing at $18.0 million for Q1 2026.
- In Q1 2026, Inventory Average rose 4.15% year-over-year to $18.0 million; the TTM figure through Mar 2026 stood at $18.0 million (up 4.15% YoY), while the FY2025 annual figure was $17.5 million, up 14.68% from the prior year.
- Inventory Average came in at $18.0 million for Q1 2026 at Vericel, up from $17.9 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $18.0 million in Q1 2026 to a low of $12.9 million in Q4 2023.
- A 5-year average of $15.6 million and a median of $15.7 million in 2023 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average jumped 41.1% in 2022 and dropped 21.42% in 2023, its largest moves.
- Vericel's Inventory Average stood at $16.4 million in 2022, then retreated by 21.42% to $12.9 million in 2023, then gained by 28.87% to $16.6 million in 2024, then advanced by 7.81% to $17.9 million in 2025, then climbed by 0.55% to $18.0 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $18.0 million, $17.9 million, and $17.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | 17.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.96 Mn |
| Dec 31, 2025 | 17.86 Mn |
| Sep 30, 2025 | 17.49 Mn |
| Jun 30, 2025 | 16.97 Mn |
| Mar 31, 2025 | 17.24 Mn |
| Dec 31, 2024 | 16.56 Mn |
| Sep 30, 2024 | 15.32 Mn |
| Jun 30, 2024 | 14.22 Mn |
| Mar 31, 2024 | 13.32 Mn |
| Dec 31, 2023 | 12.85 Mn |
| Sep 30, 2023 | 13.25 Mn |
| Jun 30, 2023 | 14.63 Mn |
| Mar 31, 2023 | 15.68 Mn |
| Dec 31, 2022 | 16.36 Mn |
| Sep 30, 2022 | 16.33 Mn |
| Jun 30, 2022 | 15.16 Mn |
| Mar 31, 2022 | 13.88 Mn |
| Dec 31, 2021 | 13.22 Mn |
| Sep 30, 2021 | 13.01 Mn |
| Jun 30, 2021 | 11.64 Mn |
| Mar 31, 2021 | 9.84 Mn |
| Dec 31, 2020 | 9.72 Mn |
| Sep 30, 2020 | 9.25 Mn |
| Jun 30, 2020 | 7.85 Mn |
| Mar 31, 2020 | 7.05 Mn |
| Dec 31, 2019 | 6.82 Mn |
| Sep 30, 2019 | 5.81 Mn |
| Jun 30, 2019 | 4.43 Mn |
| Mar 31, 2019 | 3.81 Mn |
| Dec 31, 2018 | 3.60 Mn |
| Sep 30, 2018 | 3.68 Mn |
| Jun 30, 2018 | 3.82 Mn |
| Mar 31, 2018 | 3.85 Mn |
| Dec 31, 2017 | 3.92 Mn |
| Sep 30, 2017 | 3.60 Mn |
| Jun 30, 2017 | 3.56 Mn |
| Mar 31, 2017 | 3.72 Mn |
| Dec 31, 2016 | 3.55 Mn |
| Sep 30, 2016 | 3.00 Mn |
| Jun 30, 2016 | 2.17 Mn |
| Mar 31, 2016 | 1.66 Mn |
| Dec 31, 2015 | 1.51 Mn |
| Sep 30, 2015 | 1.86 Mn |
| Jun 30, 2015 | 2.04 Mn |
| Mar 31, 2015 | 1.96 Mn |
| Dec 31, 2014 | 1.82 Mn |
| Sep 30, 2014 | 1.82 Mn |